PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Addiction. Author manuscript; available in PMC 2009 December 15.
Published in final edited form as:
PMCID: PMC2794245
NIHMSID: NIHMS160534

Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey

Abstract

Aims

Continued progress in etiological research and prevention science requires more precise information concerning the specific stages at which socio-demographic variables are implicated most strongly in transition from initial substance use to dependence. The present study examines prospective associations between socio-demographic variables and the subsequent onset of alcohol and drug dependence using data from the National Comorbidity Survey (NCS) and the NCS Follow-up survey (NCS-2).

Design

The NCS was a nationally representative survey of the prevalence and correlates of DSM-III-R mental and substance disorders in the United States carried out in 1990–2002. The NCS-2 re-interviewed a probability subsample of NCS respondents a decade after the baseline survey. Baseline NCS socio-demographic characteristics and substance use history were examined as predictors of the first onset of DSM-IV alcohol and drug dependence in the NCS-2.

Participants

A total of 5001 NCS respondents were re-interviewed in the NCS-2 (87.6% of baseline sample).

Findings

Aggregate analyses demonstrated significant associations between some baseline socio-demographic variables (young age, low education, non-white ethnicity, occupational status) but not others (sex, number of children, residential area) and the subsequent onset of DSM-IV alcohol or drug dependence. However, conditional models showed that these risk factors were limited to specific stages of baseline use. Moreover, many socio-demographic variables that were not significant in the aggregate analyses were significant predictors of dependence when examined by stage of use.

Conclusions

The findings underscore the potential for socio-demographic risk factors to have highly specific associations with different stages of the substance use trajectory.

Keywords: Alcohol dependence, demographic factors, drug dependence, epidemiology, prospective, substance-related disorders, risk

INTRODUCTION

The considerable impact of alcohol and drug dependence on morbidity and mortality in the general population [14] has positioned these disorders as important international public health priorities. Although numerous research domains have contributed to the identification of correlates or risk factors for these conditions, epidemiological research has demonstrated especially consistent links with a number of socio-demographic variables. Rates of both disorders are found usually to increase in community surveys as a function of male sex, younger age, lower education, unmarried status, low income and other variables indicative of social disadvantage that often concentrate together within population subgroups [522]. Numerous studies have also shown that early age of first use is a significant predictor of subsequent transitions from alcohol or drug use to dependence [10,2329]. These results have contributed over previous decades to the development of successful prevention efforts that target high-risk segments of the population [30].

Investigations of nationally representative samples provide necessary descriptive information for developing theories to explain underlying mechanisms of association between socio-demographic characteristics and substance dependence. However, two limitations of previous descriptive research may have hindered the precision at which etiological models and specific hypotheses have been formulated. A first issue is the lack of knowledge about how socio-demographic characteristics may be associated differentially with specific stages of the substance use trajectory. The most common approach to identifying socio-demographic correlates of disorder has been to denote significant predictors among all individuals in a given sample, regardless of stage of use. However, recent epidemiological studies that have examined determinants of transitions across different stages of substance use have demonstrated that commonly reported associations in aggregate analyses, such as those observed for gender and ethnicity, may have highly different or even opposite effects, depending on stage of use examined [3135]. The ‘one size fits all’ approach of aggregate descriptive analyses may therefore explain partially the minimal or modest success of some forms of prevention (for reviews see [3638]), and may have contributed to the difficulty at which mechanisms of association are investigated.

A second important limitation is the almost full reliance upon cross-sectional survey data and retrospective reporting of disorder onset. Retrospective assessment may increase the risk of ‘forward telescoping’ [39], a bias whereby the dating of events or disorder onset is estimated to occur closer to the time of interview than is in fact the case. This bias, as well as forgetfulness and other memory distortions, have their greatest impact when assessing life-time disorder history in cross-sectional surveys. More fundamentally, the scarcity of prospective research in nationally representative samples has also hindered the identification of socio-demographic risk and protective factors from among the numerous correlates of these disorders. These former terms are applicable only to variables that precede the outcome of interest, that are associated with the probability of the outcome’s occurrence and that may be used to divide a population into high- or low-risk groups [40,41]. Prospective research is therefore necessary to minimize memory biases and to confirm the nature of associations observed for common socio-demographic characteristics.

The present investigation examines the associations of socio-demographic variables with the subsequent first onset of alcohol and drug dependence using data from a nationally representative two-wave panel survey of the US population that was interviewed originally in 1990–1992, and then again a decade later. In addition to estimating the aggregate associations of baseline socio-demographic variables with the subsequent onset of alcohol and drug dependence, associations are examined in subsamples defined by stage of use at baseline (never use, use without abuse, abuse without dependence) and by including controls for age of use and polysubstance use, abuse or dependence. A principal objective is to compare aggregate and stage-specific analyses directly in order to uncover the dynamic nature of risk posed by socio-demographic variables and therefore to provide more precise descriptions of their associations with these disorders.

METHOD

Sample

Data come from the 5001 respondents who participated in the 1990–1992 National Comorbidity Survey (NCS) and the 2001–2003 NCS follow-up survey (NCS-2). The baseline NCS [42] was a nationally representative US survey of the prevalence and correlates of DSM-III-R mental and substance disorders that was administered to 8098 respondents aged 15–54 years between 1990 and 1992. The response rate was 82.4%. Interviews were conducted by professional survey interviewers and administered in two parts. Part I, which included the core diagnostic interview, was administered to all respondents. Part II, which included assessments of additional disorders and risk factors, was administered to a probability subsample of 5877 respondents including all those in the age range 15–24, all others with any life-time DSM-III-R disorder assessed in part I and a random subsample of remaining part I respondents. The part II sample was weighted to adjust for differential probabilities of selection and for non-response bias. Further details about the NCS design and weighting are reported elsewhere [42].

The NCS-2 sought to trace and re-interview the part II NCS respondents a decade after the NCS. Of the original 5877 part II respondents, 5463 were traced successfully, of whom 166 were deceased and 5001 re-interviewed, for a conditional response rate of 87.6%. The unconditional response rate is 72.2% (0.876 × 0.824). NCS-2 respondents were assessed using an expanded version of the baseline interview that assessed onset and course of disorders between the two surveys. Relative to other baseline NCS respondents, NCS-2 respondents were significantly more likely to be female, well educated and residents of rural areas. A propensity score adjustment weight [43] corrected for these discrepancies between respondents and non-respondents.

Diagnostic assessment

The baseline NCS assessed DSM-III-R disorders using a modification of the World Health Organization Composite International Diagnostic Interview (CIDI) version 1.1 [44], a fully structured, lay-administered diagnostic interview. DSM-IV disorders that had first onsets in the decade between the two interviews were assessed in the NCS-2 using CIDI version 3.0 [45]. Alcohol and drug dependence were assessed at the NCS-2 assessment only among individuals who reported symptoms of abuse over the previous decade. DSM organic exclusion rules were used in making diagnoses in both surveys. The NCS-2 assessment also considered first onsets of DSM-IV disorders prior to the time of the baseline interview that were not reported at baseline. These inconsistencies in reporting across surveys were resolved by coding pre-baseline disorders not reported until the follow-up interview as having occurred prior to baseline, in order to make lower-bound estimates of age at onset. Blinded clinical reappraisal interviews administered to a probability sub-sample of respondents using the Structured Clinical Interview for DSM-III-R [46] in the NCS and the Structured Clinical Interview for DSM-IV (SCID; [47]) in the NCS-2 documented generally good concordance between diagnoses based on the CIDI and independent diagnoses based on blinded clinical reappraisal interviews [48,49].

Baseline socio-demographic predictors of subsequent substance dependence

The baseline socio-demographic variables considered in the analysis include age (defined by age at interview in categories 15–24 years, 25–34 years, 35–44 years and ≥45 years); sex; race/ethnicity (non-Hispanic white, other); completed years of education [less than high school (0–11), high school (12), some college (13–15) and college graduate (16 or more)]; occupation (student, homemaker/other, employed); marital status (never married, separated/widowed/divorced and currently married/cohabitating); number of children (none, one, two or more); income [low income (less than or equal to 1.5 times the poverty line), low average (greater than 1.5–3 times the poverty line), high average (greater than 3–6 times the poverty line) and high (greater than 6 times the poverty line)]; region (Northeast, South, West, Midwest); and area (urban, metro, rural, suburban). We also included additional variables in the prediction equations to account for the use of other substances at baseline. Included here were measures of smoking stages (no regular tobacco use, weekly smoking without nicotine dependence, nicotine dependence) and either a dichotomous variable indicating life-time use of any illicit drug at baseline in predicting alcohol dependence, or four variables indicating life-time involvement in alcohol use stages (non-regular use, regular use defined as having 12 drinks in the past year but without alcohol abuse, alcohol abuse without dependence and alcohol dependence) in predicting drug dependence. We also controlled for age at onset of use and abuse of the outcome substance as well as for its recency of use and abuse as of the time of the baseline assessment.

Statistical analyses

Cross-tabulations were used to estimate conditional lifetime prevalence of first onset of alcohol and drug dependence at the NCS-2 assessment. Multivariate logistic regression analysis [50] was used to estimate associations of baseline socio-demographic variables with subsequent first onset of dependence both with and without controls for other baseline risk factors (age of onset and recency of substance use and abuse). Logistic regression coefficients and their standard errors were exponentiated to create odds ratios (ORs) and their 95% confidence intervals. Continuous predictors were divided into categories to minimize the effects of extreme values, while some categories of predictors were combined to stabilize associations when the ORs did not differ meaningfully across contiguous categories. Standard errors and significance tests were estimated using the Taylor series method [51] implemented in the SUDAAN software system [52] to adjust for the geographic clustering of the sample and the use of weights. Multivariate significance was evaluated using Wald χ2 tests based on design-corrected coefficient variance–covariance matrices. Statistical significance was evaluated using two-tailed 0.05-level tests. Due to the large number of socio-demographic variables examined, preliminary analyses were performed to identify significant predictors either among all non-dependent respondents at baseline (unconditional models) or among respondents according to stage of baseline use (conditional models). Final models included all variables that were significant in at least one of the preliminary models for alcohol or drug dependence, respectively.

RESULTS

The percentage of NCS-2 respondents who met life-time criteria at baseline for alcohol dependence was 14.3% [standard error (SE) = 0.6%, n = 1018] and 7.4% for drug dependence (SE = 0.4%, n = 529). Of all respondents without alcohol dependence at baseline, 2.3% (SE = 0.4%, n = 104) had an onset of DSM-IV alcohol dependence as of the time of the NCS-2, representing 1.3% (SE = 0.4%, n = 22) of baseline non-users, 2.7% (SE = 0.5%, n = 57) of baseline users without abuse and 3.6% (SE = 1.1%, n = 25) of baseline abusers without dependence. Of all respondents without drug dependence at baseline, 1.5% (SE = 0.2%, n = 77) had an onset of DSM-IV drug dependence, representing 0.7% (SE = 0.2%, n = 17) of baseline non-users, 2.1% (SE = 0.5%, n = 43) of baseline users without abuse and 5.0% (SE = 1.2%, n = 17) of baseline abusers without dependence. The types of substances used by individuals with NCS-2 first-onset drug dependence were cannabis (86.7%, SE = 7.6%, n = 70), cocaine (73.5%, SE = 7.0%, n = 53), stimulants (42.2%, SE = 7.0%, n = 40), hallucinogenics (36.9%, SE = 7.2%, n = 29), sedatives (35.6%, SE = 6.0%, n = 34), analgesics (31.1%, SE = 7.3%, n = 27), heroin (19.9%, SE = 5.0%, n = 17), ecstasy (17.5%, SE = 5.3%, n = 15) and inhalants (9.0%, SE = 4.1%, n = 7).

Table 1 presents the unconditional associations of baseline socio-demographic variables with first onset of alcohol and drug dependence among all NCS-2 respondents who were non-dependent as of the baseline assessment. Elevated risk of alcohol dependence (ORs 3.1–8.8) was found among respondents in the two youngest age cohorts, as well as homemakers or ‘other’ employment status (which included primarily unemployed or disabled individuals). The risk of alcohol dependence was also elevated among respondents with a baseline history of weekly smoking without dependence (OR = 2.8) or nicotine dependence (OR = 5.4). Similarly, elevated risk of drug dependence was found for young age, non-white ethnicity, low education and among individuals with a baseline history of nicotine dependence, regular alcohol use, abuse or dependence (ORs 2.3–56.7).

Table 1
Socio-demographic predictors of alcohol and drug dependence (unconditional models).

Table 2 presents findings for socio-demographic predictors of alcohol dependence by stage of baseline alcohol use, revealing important differences compared to the aggregate results. The occupational categories of student and homemaker/other employment were associated with alcohol dependence for distinct baseline populations (non-abusive users or abusers, respectively). Weekly smoking and nicotine dependence were associated with increased risk of alcohol dependence only among baseline non-users or non-abusive users of alcohol. In addition, several variables for which weak or non-significant associations were observed in the aggregate analyses emerged as significant risk factors by stage of baseline use. This was the case notably for male sex and having no children, variables that were significant risk factors for alcohol dependence among baseline non-users. Despite these numerous apparent differences, a test of whether the associations varied by stage of baseline use revealed significant interactions only for occupation (χ2 = 11.0, P = 0.027) and number of children (χ2 = 9.8, P = 0.020).

Table 2
Socio-demographic predictors of alcohol dependence by baseline stage of use (conditional models).

Concerning predictors of drug dependence by stage of baseline use, Table 3 demonstrates that while the effects of younger age were relatively equal across stages, lower education was predictive of drug dependence only among baseline non-users and non-abusive users. Non-white ethnicity was associated only weakly with drug dependence among these first two baseline stages, and the association for baseline alcohol abuse was limited to respondents who had not yet used drugs at baseline. For variables that were non-significant in the aggregate analyses, male sex was associated with increased risk of drug dependence among baseline non-users, and those living in a metro or urban area were at higher risk for dependence if they were drug abusers at baseline. Significant interactions by stage of baseline drug use were found for age (χ2 = 13.3, P = 0.004), sex (χ2 = 10.8, P = 0.004) and geographic area (χ2 = 10.7, P = 0.031).

Table 3
Socio-demographic predictors of drug dependence by baseline stage of use (conditional models).

DISCUSSION

The current findings contribute to a growing body of research investigating socio-demographic predictors of substance dependence by prior stage of use [5,25,3135,5355] and indicate that many socio-demographic characteristics as well as substance use history are associated with the onset of alcohol or drug dependence over a 10-year period. Importantly, however, none of these predictors remained significant in all the subsamples considered here, and several variables that were not significant predictors in the aggregate analyses emerged as risk factors in at least one subsample examined in the conditional models. These differences underscore the extent to which analyses that take into account baseline substance use status may provide a richer conceptualization of predictors than the more common aggregated approach. The use of two-wave panel data also allow for the term ‘risk factor’ to be used legitimately to describe these associations [40,41], and the findings add to other prospective research in community samples [10,11,24,56,57] by examining a wider range of socio-demographic characteristics as well as multiple stages of baseline use.

The present findings indicate nonetheless that caution is warranted in interpreting differences in the role of socio-demographic factors by stage of use compared to those of aggregate analyses, as only a minority of these differences could be confirmed by formal interaction tests across stages of substance use. Many apparent discrepancies in the significance of predictors for different stages may therefore be attributable to relatively minor differences in effect sizes or other factors that do not reflect salient changes in the patterns of risk factor expression. The lack of association between certain variables with alcohol or drug dependence may also be attributable to statistical power issues. However, the observation that several socio-demographic risk factors do vary by stage of baseline use has important implications for the prevention of alcohol and drug dependence. Many prevention programs in the United States, including the majority of those examined for effectiveness and characterized as exemplary by national agencies, integrate strategies to address psychosocial or demographic risk factors [30]. Information concerning many of these variables is derived primarily from descriptive epidemiology, using cross-sectional surveys that rely on aggregate analyses. The present findings indicate that such information, even when prospective, may not permit the identification of subgroups of individuals for which socio-demographic risk factors are most relevant. The reliance on aggregate findings could therefore explain partially the highly variable efficacy of existing prevention programs [3638], in particular considering that the aggregate analytical approach would fully ignore several socio-demographic characteristics that have predictive value for the onset of alcohol or drug dependence. Significant associations observed for certain variables among non-users of alcohol but not among abusers, for example, may indicate that this variable is perhaps integrated more appropriately into universal prevention efforts than into indicated programs and treatment. The refinement of prevention science based on conditional analyses may therefore lead to changes in strategies that target high-risk groups by stage of use, as well as adjustment of resources for subpopulations and regions that are most vulnerable to developing dependence.

The specific variables examined in this investigation are among the most frequent socio-demographic characteristics analyzed in descriptive epidemiology, and they are often classified broadly into individual or environmental risk factors [58]. However, the actual mechanisms of risk underlying the observed associations are highly complex and may reflect numerous biological, psychological or social influences for any given variable. An illustration of this complexity is observed readily for characteristics such as respondent sex. While differences have been observed in the reinforcing effects of certain substances by sex, and sex hormones may be implicated in vulnerability to transition across substance use stages [59,60], normative peer behavior or social values also encourage substance use differently by gender [6163]. In the same way, numerous individual and environmental risk factors may interact to determine the final expression of substance use patterns observed in descriptive epidemiology. For example, younger cohorts are at greatest risk for the onset of use, abuse and dependence, but this developmental trajectory can also be affected by interactions between other risk factors, such as sex and genetic susceptibility [64]. For these reasons, the identification of socio-demographic predictors of alcohol or drug dependence is only an initial, albeit necessary, starting point for identifying high-risk populations in the allocation of resources or in the advancement of research concerning underlying mechanisms.

The contribution of this investigation is fostered by its prospective design and the increased precision of analyses that clarify the stage at which different socio-demographic risk factors have their greatest predictive value. Additional strengths include the use of direct diagnostic interviews within a large, nationally representative sample. In interpreting these findings, however, it is important to conceptualize risk factors relative to the time-frame used in their identification. The 10-year period covered by this study indicates that even the youngest age cohort at baseline had passed through the age of greatest risk for alcohol or drug dependence by the follow-up assessment. However, as a proportion of alcohol or drug dependence cases will occur subsequently in this sample, this time-frame may not capture the full predictive value of all socio-demographic characteristics examined. The numerous socio-demographic variables examined here included certain characteristics that may have changed over the assessment period (e.g. education status), while others remained stable (e.g. sex). In any case, their interpretation is limited to their status as assessed at baseline. Concerning drug dependence, it remains possible that different risk factors would be identified if analyses were performed by specific drug type, and it is important to note that both drug and alcohol dependence were assessed only among respondents at follow-up who met criteria for abuse. Although this gated assessment encompasses the majority of individuals who eventually develop dependence and has little impact on the significance of socio-demographic correlates [65,66], this approach results in lower overall prevalence rates [67]. In addition, the risk factors for individuals who develop drug or alcohol dependence without a life-time history of abuse may be highly specific or different from the present findings. Additional prospective research concerning how socio-demographic risk factors vary across the full trajectory of alcohol and drug use is now needed to adjust risk formulas and increase the precision of prevention strategies in targeting vulnerable individuals.

Acknowledgments

The NCS data collection was supported by the National Institute of Mental Health (NIMH; R01MH46376). The NCS-2 data collection was supported by the National Institute on Drug Abuse (NIDA; R01DA012058). Data analysis for this paper was additionally supported by NIMH grants R01MH070884, R01MH077883 and U01MH060220, with supplemental support from the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044780) and the John W. Alden Trust. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or US government. A complete list of NCS and NCS-2 publications can be found at http://www.hcp.med.harvard.edu/ncs/. Send correspondence to ude.dravrah.dem.pch@scn. The NCS-2 is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork and consultation on data analysis. These activities were supported by the National Institute of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13MH066849, R01MH069864 and R01DA016558), the Fogarty International Center (FIRCA R03TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline and Bristol-Myers Squibb. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/.

Footnotes

Declarations of interest

None.

References

1. Degenhardt L, Hall W, Lynskey M, Warner-Smith M. Illicit drug use. In: Ezzati M, Lopez AD, Rodgers A, Murray R, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. 2. chapter 13. Geneva: World Health Organization; 2004. pp. 1109–76.
2. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol use. In: Ezzati M, Lopez AD, Rodgers A, Murray R, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. 2. chapter 12. Geneva: World Health Organization; 2004. pp. 959–1108.
3. Rehm J, Taylor B, Patra J. Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002. Addiction. 2006;101:1086–95. [PubMed]
4. World Health Organization. The World Health Report 2002—Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization; 2002. [PubMed]
5. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the national comorbidity survey. Exp Clin Psychopharmacol. 1994;2:244–68.
6. Diala CC, Mutaner C, Walrath C. Gender, occupational, and socioeconomic correlates of alcohol and drug abuse among U.S. rural, metropolitan, and urban residents. Am J Drug Alcohol Abuse. 2004;30:409–28. [PubMed]
7. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. Arch Gen Psychiatry. 2007;64:566–76. [PubMed]
8. Crum RM, Chan YF, Chen LS, Storr CL, Anthony JC. Incidence rates for alcohol dependence among adults: prospective data from the Baltimore epidemiologic catchment area follow-up survey, 1981–1996. J Stud Alcohol. 2005;66:795–805. [PubMed]
9. Degenhardt L, Lynskey M, Hall W. Cohort trends in the age of initiation of drug use in Australia. Aust NZ J Public Health. 2000;24:421–6. [PubMed]
10. Grant BF, Stinson FS, Harford TC. Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up. J Subst Abuse. 2001;13:493–504. [PubMed]
11. Harford TC, Yi HY, Hilton ME. Alcohol abuse and dependence in college and noncollege samples: a ten-year prospective follow-up in a national survey. J Stud Alcohol. 2006;67:803–9. [PubMed]
12. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64:830–42. [PubMed]
13. Johnson RA, Gerstein DR. Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919. Aust J Public Health. 1998;88:27–33. [PubMed]
14. Kerr WC, Greenfield TK, Bond J, Ye Y, Rehm J. Age–period–cohort influences on trends in past year marijuana use in the U.S. from the 1984, 1990, 1995 and 2000 national alcohol surveys. Drug Alcohol Depend. 2007;86:132–8. [PubMed]
15. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:593–602. [PubMed]
16. Konings E, Dubois-Arber F, Narring F, Michaud PA. Identifying adolescent drug users: results of a national survey on adolescent health in Switzerland. J Adolesc Health. 1995;16:240–7. [PubMed]
17. Lynskey M, White V, Hill D, Letcher T, Hall W. Prevalence of illicit drug use among youth: results from the Australian school students’ alcohol and drugs survey. Aust NZ J Public Health. 1999;23:519–24. [PubMed]
18. Melchior M, Chastang JF, Goldberg P, Fombonne E. High prevalence rates of tobacco, alcohol and drug use in adolescents and young adults in France: results from the GAZEL youth study. Addict Behav. 2008;33:122–33. [PubMed]
19. Perkonigg A, Pfister H, Hofler M, Frohlich C, Zimmermann P, Lieb R, et al. Substance use and substance use disorders in a community sample of adolescents and young adults: incidence, age effects and patterns of use. Addict Res. 2006;12:187–96. [PubMed]
20. von Sydow K, Lieb R, Pfister H, Höfler M, Wittchen HU. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults—a transient phenomenon? Results from a longitudinal community study. Drug Alcohol Depend. 2002;66:147–59. [PubMed]
21. Wallace JM, Bachman JG, O’Malley PM, Schulenberg JE, Cooper SM, Johnston LD. Gender and ethnic differences in smoking, drinking and illicit drug use among American 8th, 10th, and 12th grade students 1976–2000. Addiction. 2003;98:225–34. [PubMed]
22. Warner LA, Kessler RC, Hughes M. Prevalence and correlates of drug use and dependence in the United States: results from the national comorbidity survey. Arch Gen Psychiatry. 1995;52:219–29. [PubMed]
23. Anthony JC, Petronis KR. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend. 1995;40:9–15. [PubMed]
24. Behrendt S, Wittchen HU, Höfler M, Lieb R, Beesdo K. Transitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation? Drug Alcohol Depend. 2009;99:68–78. [PubMed]
25. Chen CY, O’Brien MS, Anthony JC. Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001. Drug Alcohol Depend. 2005;79:11–22. [PubMed]
26. Grant BF, Dawson DA. Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1997;9:103–10. [PubMed]
27. Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1998;10:163–73. [PubMed]
28. McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction. 2007;102:1931–2. [PMC free article] [PubMed]
29. Pitkanen T, Lyyra AL, Pulkkinen L. Age of onset of drinking and the use of alcohol in adulthood: a follow-up study from age 8–42 for females and males. Addiction. 2005;100:652–61. [PubMed]
30. Winters KC, Fawkes T, Fahnhorst T, Botzet A, August G. A synthesis of exemplary drug abuse prevention programs in the United States. J Subst Abuse Treat. 2007;32:371–80. [PubMed]
31. Kalaydjian A, Swendsen J, Chiu WT, Dierker L, Degenhardt L, Glantz M, et al. Predictors of transitions across stages of alcohol use, disorders and remission in the national comorbidity survey-replication. Compr Psychiatry. 2009 in press. [PMC free article] [PubMed]
32. O’Brien MS, Anthony JC. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000–2001. Neuropsychopharmacology. 2005;30:1006–18. [PubMed]
33. Swendsen J, Anthony JC, Conway KP, Degenhardt L, Dierker L, Glantz M, et al. Improving targets for the prevention of drug use disorders: sociodemographic predictors of transitions across drug use stages in the National Comorbidity Survey Replication. Prev Med. 2008;47:629–34. [PMC free article] [PubMed]
34. Van Etten ML, Neumark YD, Anthony JC. Male–female differences in the earliest stages of drug involvement. Addiction. 1999;94:1413–9. [PubMed]
35. Van Etten ML, Anthony JC. Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Depend. 1999;54:117–25. [PubMed]
36. Cuijpers P. Three decades of drug prevention research. Drugs Educ Prev Pol. 2003;10:7–20.
37. Hawkins D, Catalano R, Miller J. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull. 1992;112:64–105. [PubMed]
38. Toumbourou JW, Stockwell T, Neighbors C, Marlatt GA, Sturge J, Rehm J. Interventions to reduce harm associated with adolescent substance use. Lancet. 2007;369:1391–401. [PubMed]
39. Johnson EO, Schultz L. Forward telescoping bias in reported age of onset: an example from cigarette smoking. Int J Methods Psychiatr Res. 2005;14:119–29. [PubMed]
40. Kraemer H, Kazdin A, Offord D, Kessler RC, Jensen P, Kupfer D. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54:337–43. [PubMed]
41. Offord D, Kraemer H. Risk factors and prevention. Evid Based Ment Health. 2000;3:70–1.
42. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19. [PubMed]
43. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55.
44. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069–77. [PubMed]
45. Kessler RC, Ustun TB. The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) Int J Methods Psychiatr Res. 2004;13:93–121. [PubMed]
46. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624–629. [PubMed]
47. First MB, Spitzer RL, Gibbon M, Williams JBW. Biometrics Research. New York: New York State Psychiatric Institute; 2002. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP)
48. Kessler RC, Wittchen H-U, Abelson JM, McGonagle KA, Schwarz N, Kendler KS, et al. Methodological studies of the Composite International Diagnostic Interview (CIDI) in the US national comorbidity survey. Int J Methods Psychiatr Res. 1998;7:33–55.
49. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, de Girolamo G, Guyer ME, Jin R, et al. Concordance of the Composite International Diagnostic Interview version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res. 2006;15:167–80. [PubMed]
50. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley & Son; 1989.
51. Wolter KM. Introduction to Variance Estimation. New York: Springer-Verlag; 1985.
52. Research Triangle Institute. SUDAAN: Professional Software for Survey Data Analysis, 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
53. Sartor CE, Lynskey MT, Heath AC, Jacob T, True W. The role of childhood risk factors in initiation of alcohol use and progression to alcohol dependence. Addiction. 2007;102:216–25. [PubMed]
54. Stone AL, O’Brien MS, De La Torre A, Anthony JC. Who is becoming hallucinogen dependent soon after hallucinogen use starts? Drug Alcohol Depend. 2007;87:153–63. [PubMed]
55. Wagner FA, Anthony JC. Male–female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Depend. 2007;86:191–8. [PubMed]
56. Behrendt S, Wittchen HU, Höfler M, Lieb R, Low NC, Rehm J, et al. Risk and speed of transitions to first alcohol dependence symptoms in adolescents: a 10-year longitudinal community study in Germany. Addiction. 2008;103:1638–47. [PubMed]
57. Wittchen HU, Behrendt S, Höfler M, Perkonigg A, Lieb R, Bühringer G, et al. What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res. 2008;17:S16–29. [PubMed]
58. World Health Organization. Neuroscience of Psychoactive Substance Use and Dependence. Geneva: World Health Organization; 1994.
59. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol. 2008;29:36–47. [PMC free article] [PubMed]
60. Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci Biobehav Rev. 2004;28:533–46. [PubMed]
61. Huselid RF, Cooper ML. Gender roles as mediators of sex differences in adolescent alcohol use and abuse. J Health Soc Behav. 1992;33:348–62. [PubMed]
62. Kulis S, Marsiglia FF, Hurdle D. Gender identity, ethnicity, acculturation, and drug use: exploring differences among adolescents in the Southwest. J Commun Psychol. 2003;31:167–88. [PMC free article] [PubMed]
63. Williams R, Ricciardelli LA. Gender congruence in confirmatory and compensatory drinking. J Psychol. 1999;133:323–31. [PubMed]
64. Derringer J, Krueger RF, Mcgue M, Lacono WG. Genetic and environmental contributions to the diversity of substances used in adolescent twins: a longitudinal study of age and sex effects. Addiction. 2008;103:1744–51. [PMC free article] [PubMed]
65. Degenhardt L, Bohnert KM, Anthony JC. Assessment of cocaine and other drug dependence in the general population: ‘gated’ versus ‘ungated’ approaches. Drug Alcohol Depend. 2008;93:227–32. [PMC free article] [PubMed]
66. Degenhardt L, Cheng H, Anthony J. Assessing cannabis dependence in community surveys: methodological issues. Int J Methods Psychiatr Res. 2007;16:43–51. [PubMed]
67. Grant BF, Compton WM, Crowley TJ, Hasin DS, Helzer JE, Li TK, et al. Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry. 2007;64:379–80. [PubMed]